Treatment of micro-albuminuria or proteinuria with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) may slow the progression of CKD to end-stage renal disease (ESRD). Here, ACE is linked to stage 5 chronic kidney disease.